Oxford Biomedica/£OXB
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX
About Oxford Biomedica
Ticker
£OXB
Sector
Primary listing
LSE
Employees
977
Headquarters
Website
Oxford Biomedica Metrics
BasicAdvanced
£740m
-
-£0.27
1.04
-
Price and volume
Market cap
£740m
Beta
1.04
52-week high
£9.62
52-week low
£3.48
Average daily volume
292k
Financial strength
Current ratio
2.204
Quick ratio
1.924
Long term debt to equity
155.531
Total debt to equity
162.161
Interest coverage (TTM)
-2.24%
Profitability
EBITDA (TTM)
-19.562
Gross margin (TTM)
39.10%
Net profit margin (TTM)
-17.85%
Operating margin (TTM)
-19.20%
Effective tax rate (TTM)
4.04%
Revenue per employee (TTM)
£170,000
Management effectiveness
Return on assets (TTM)
-7.27%
Return on equity (TTM)
-40.37%
Valuation
Price to revenue (TTM)
4.046
Price to book
8.09
Price to tangible book (TTM)
11.17
Price to free cash flow (TTM)
-160.493
Free cash flow yield (TTM)
-0.62%
Free cash flow per share (TTM)
-0.038
Growth
Revenue change (TTM)
31.01%
Earnings per share change (TTM)
-35.52%
3-year revenue growth (CAGR)
6.42%
10-year revenue growth (CAGR)
26.64%
3-year earnings per share growth (CAGR)
-13.29%
10-year earnings per share growth (CAGR)
0.61%
What the Analysts think about Oxford Biomedica
Analyst ratings (Buy, Hold, Sell) for Oxford Biomedica stock.
Oxford Biomedica Financial Performance
Revenues and expenses
Oxford Biomedica Earnings Performance
Company profitability
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Oxford Biomedica stock?
Oxford Biomedica (OXB) has a market cap of £740M as of April 30, 2026.
What is the P/E ratio for Oxford Biomedica stock?
The price to earnings (P/E) ratio for Oxford Biomedica (OXB) stock is 0 as of April 30, 2026.
Does Oxford Biomedica stock pay dividends?
No, Oxford Biomedica (OXB) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Oxford Biomedica dividend payment date?
Oxford Biomedica (OXB) stock does not pay dividends to its shareholders.
What is the beta indicator for Oxford Biomedica?
Oxford Biomedica (OXB) has a beta rating of 1.04. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.